JP2024516886A5 - - Google Patents
Info
- Publication number
- JP2024516886A5 JP2024516886A5 JP2023568736A JP2023568736A JP2024516886A5 JP 2024516886 A5 JP2024516886 A5 JP 2024516886A5 JP 2023568736 A JP2023568736 A JP 2023568736A JP 2023568736 A JP2023568736 A JP 2023568736A JP 2024516886 A5 JP2024516886 A5 JP 2024516886A5
- Authority
- JP
- Japan
- Prior art keywords
- dose
- saving
- subject
- composition according
- steroid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163187485P | 2021-05-12 | 2021-05-12 | |
| US63/187,485 | 2021-05-12 | ||
| US202163230113P | 2021-08-06 | 2021-08-06 | |
| US63/230,113 | 2021-08-06 | ||
| PCT/EP2022/062770 WO2022238479A1 (en) | 2021-05-12 | 2022-05-11 | Inhibitor of type 1 interferon receptor steroid sparing in systemic lupus erythematosus patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516886A JP2024516886A (ja) | 2024-04-17 |
| JP2024516886A5 true JP2024516886A5 (https=) | 2025-05-19 |
Family
ID=82019468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568736A Pending JP2024516886A (ja) | 2021-05-12 | 2022-05-11 | 全身性エリテマトーデス患者における１型インターフェロン受容体阻害剤のステロイド節約 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250002591A1 (https=) |
| EP (1) | EP4337696A1 (https=) |
| JP (1) | JP2024516886A (https=) |
| KR (1) | KR20240006549A (https=) |
| AU (1) | AU2022274306A1 (https=) |
| BR (1) | BR112023023391A2 (https=) |
| CA (1) | CA3219401A1 (https=) |
| IL (1) | IL308128A (https=) |
| TW (1) | TW202313103A (https=) |
| WO (1) | WO2022238479A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113278071B (zh) * | 2021-05-27 | 2021-12-21 | 江苏荃信生物医药股份有限公司 | 抗人干扰素α受体1单克隆抗体及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7662381B2 (en) | 2004-06-21 | 2010-02-16 | Medarex, Inc. | Interferon alpha receptor 1 antibodies and their uses |
| KR20160070165A (ko) | 2008-02-08 | 2016-06-17 | 메디뮨 엘엘씨 | Ｆｃ 리간드 친화성이 감소된 항-ＩＦＮＡＲ１ 항체 |
| CA2772921A1 (en) | 2009-09-03 | 2011-03-10 | Medimmune, Llc | Type 1 interferon diagnostic |
| RS64263B1 (sr) * | 2015-08-19 | 2023-07-31 | Astrazeneca Ab | Stabilna anti-ifnar1 formulacija |
| CN106243226B (zh) | 2016-08-05 | 2019-02-12 | 北京智仁美博生物科技有限公司 | 抗人ifnar1的抗体及其用途 |
| CN113278070B (zh) | 2021-04-25 | 2022-06-14 | 福州迈新生物技术开发有限公司 | 抗ck17蛋白单克隆抗体及其细胞株、制备方法和应用 |
-
2022
- 2022-05-11 IL IL308128A patent/IL308128A/en unknown
- 2022-05-11 EP EP22729455.0A patent/EP4337696A1/en active Pending
- 2022-05-11 KR KR1020237038761A patent/KR20240006549A/ko active Pending
- 2022-05-11 JP JP2023568736A patent/JP2024516886A/ja active Pending
- 2022-05-11 CA CA3219401A patent/CA3219401A1/en active Pending
- 2022-05-11 AU AU2022274306A patent/AU2022274306A1/en active Pending
- 2022-05-11 BR BR112023023391A patent/BR112023023391A2/pt unknown
- 2022-05-11 US US18/559,907 patent/US20250002591A1/en active Pending
- 2022-05-11 WO PCT/EP2022/062770 patent/WO2022238479A1/en not_active Ceased
- 2022-05-12 TW TW111117746A patent/TW202313103A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025131730A (ja) | Ｉｌ－４ｒ拮抗薬の投与により喘息を処置または予防するための方法 | |
| EP4114465B1 (en) | Anti-ifnar1 dosing regime for subcutaneous injection | |
| JP6746495B2 (ja) | ベンラリツマブを使用して喘息の増悪率を低減する方法 | |
| US20250051453A1 (en) | Methods for treating bullous pemphigoid using fcrn antagonists | |
| JP2024530954A5 (https=) | ||
| JP2023546361A5 (https=) | ||
| JP2024518735A5 (https=) | ||
| US20250002589A1 (en) | Treatment of cutaneous lupus erythematous | |
| JP2024519196A5 (https=) | ||
| JP2024516886A5 (https=) | ||
| JP2024543509A5 (https=) | ||
| Luhder et al. | Traditional concepts and future avenues of glucocorticoid action in experimental autoimmune encephalomyelitis and multiple sclerosis therapy | |
| JP2024527001A5 (https=) | ||
| US20250002591A1 (en) | Inhibitor of type 1 interferon receptor steroid sparing in systemic lupus erythermatosus patients | |
| CN120344259A (zh) | 狼疮的治疗 | |
| WO2024241156A1 (en) | Treatment of lupus | |
| CN117337305A (zh) | 系统性红斑狼疮患者中的1型干扰素受体抑制剂类固醇节制 | |
| EA052183B1 (ru) | Лечение кожной красной волчанки | |
| HK40087032A (en) | Anti-ifnar1 dosing regime for subcutaneous injection | |
| HK40087032B (en) | Anti-ifnar1 dosing regime for subcutaneous injection | |
| CN117677638A (zh) | 狼疮的治疗 | |
| CN117157099A (zh) | 用于皮下注射的抗ifnar1给药方案 | |
| JP2023182667A (ja) | エルトロンボパグの投与計画 |